Compare PLBL & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLBL | TMDX |
|---|---|---|
| Founded | 2021 | 1998 |
| Country | Indonesia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.5B |
| IPO Year | N/A | 2019 |
| Metric | PLBL | TMDX |
|---|---|---|
| Price | $5.46 | $74.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $148.22 |
| AVG Volume (30 Days) | 9.5K | ★ 1.4M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | N/A | $24.25 |
| Revenue Next Year | N/A | $18.75 |
| P/E Ratio | ★ N/A | $355.70 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $5.21 | $60.11 |
| 52 Week High | $13.48 | $156.00 |
| Indicator | PLBL | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 32.62 | 48.93 |
| Support Level | N/A | $64.90 |
| Resistance Level | $8.27 | $120.60 |
| Average True Range (ATR) | 0.66 | 3.91 |
| MACD | -0.12 | 2.21 |
| Stochastic Oscillator | 17.37 | 92.52 |
Polibeli Group Ltd is engaged in goods trading and others to promote the circulation of goods with a focus on making trading easier. The products offered by the company include consumer electronic accessories, household appliances, skincare products, oral-care products, cosmetics products, toys and game products, and health-care products. Geographically, the company derives the majority of its revenue from Japan.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.